title: Severe 5-fluorouracil toxicity possibly secondary to dihydropyrimidine dehydrogenase deficiency in a breast cancer patient with osteogenesis imperfecta.
authors.forename: P
authors.initials: P
authors.lastname: Beuzeboc
authors.forename: J Y
authors.initials: JY
authors.lastname: Pierga
authors.forename: D
authors.initials: D
authors.lastname: Stoppa-Lyonnet
authors.forename: M C
authors.initials: MC
authors.lastname: Etienne
authors.forename: G
authors.initials: G
authors.lastname: Milano
authors.forename: P
authors.initials: P
authors.lastname: Pouillart
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D042943:Dihydrouracil Dehydrogenase (NADP); D005260:Female; D005472:Fluorouracil / Q000009:adverse effects*; D006801:Humans; D008875:Middle Aged; D010013:Osteogenesis Imperfecta / Q000150:complications*; D010088:Oxidoreductases / Q000172:deficiency*
chemical_list: D000964:Antimetabolites, Antineoplastic; D010088:Oxidoreductases; D042943:Dihydrouracil Dehydrogenase (NADP); D005472:Fluorouracil